Mr. George Montgomery has worked for more than 30 years in public & private capital markets, M&A and partnering transactions. He is the current CFO at Neuvogen; founding investor at Retromer Therapeutics, Senior Advisor to ALTi Tiedemann Global ($68bn AUM). He leads the Audit Committee of the Ashvattha Therapeutics BoD.

He was former Managing Director at JPMorgan H&Q, Cowen; Managing Director at WestRiver Group; partner at Gurnet Point Capital, a $2Bn AUM; Board Member at portfolio companies including Boston Pharmaceuticals, Crossover Health. He was the CFO at Coherus Biosciences until the IPO.